# Wuhan Zhihua Technology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/wuhan-zhihua-technology-co

- Industry: Pharmaceuticals
- Headquarters: Wuhan, China
- Website: www.chemical.ai
- Total disclosed funding: $34M
- Latest round: Series B (Oct 1, 2022)
- Investors on record: 7

## About

Established in 2018 and based in Wuhan, China, Wuhan Zhihua Technology Co., Ltd is a technology company that focuses on the research and development of computer-aided
synthesis planning based on artificial intelligence and chemical big data. In November 2022, it raised approximately CNY 100 million led by Changjiang Innovation Fund Management (Wuhan), with participation from CreditEase Wealth Management (Beijing).

The company engages in the development of AI chemical synthesis automation platforms. Its main product is Chemical. AI. Chemical.AI provides synthetic planning technical services for pharmaceutical companies, CROs, and academic and scientific research institutions based on artificial intelligence and chemical informatics. It focuses on AI-assisted chemical synthesis route design which only takes a few seconds to a few minutes to find the synthesis route and recommend the most appropriate synthesis scheme for researchers.

## Funding rounds

- Series B, Oct 1, 2022, $14M — CreditEase Wealth Management, Changjiang Innovation Fund Management (Wuhan) Co., Ltd
- Series A, Aug 9, 2021, $15M — Hong Shan, Source Code Capital, Frees Fund, Huafang Capital
- Series A, Mar 5, 2021, $4.6M — Hong Shan, Frees Fund, Nest.Bio Labs

## Investors

- Hong Shan — Series A
- Frees Fund (https://capitalatlas.ai/funds/frees-fund) — Series A
- Nest.Bio Labs (https://capitalatlas.ai/funds/nest-bio-labs) — Series A
- Source Code Capital (https://capitalatlas.ai/funds/source-code-capital) — Series A
- Huafang Capital (https://capitalatlas.ai/funds/huafang-capital) — Series A
- CreditEase Wealth Management (https://capitalatlas.ai/funds/creditease-wealth-management) — Series B
- Changjiang Innovation Fund Management (Wuhan) Co., Ltd — Series B